Last Updated: May 11, 2026

Suppliers and packagers for ELIMITE


✉ Email this page to a colleague

« Back to Dashboard


ELIMITE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Aurobindo Pharma Usa ELIMITE permethrin CREAM;TOPICAL 019855 NDA Aurobindo Pharma Limited 59651-834-60 1 TUBE in 1 CARTON (59651-834-60) / 60 g in 1 TUBE 2024-01-22
Aurobindo Pharma Usa ELIMITE permethrin CREAM;TOPICAL 019855 NDA AUTHORIZED GENERIC Aurobindo Pharma Limited 84386-073-60 1 TUBE in 1 CARTON (84386-073-60) / 60 g in 1 TUBE 2024-01-22
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for ELIMITE

Last updated: April 24, 2026

Who Supplies Elimite (Permethrin 5%) for Pharmaceutical Use?

Elimite is a branded topical drug whose active ingredient is permethrin 5% (for scabies). The supply chain is typically split into (1) drug product manufacturers that fill/finish the branded medicine and (2) ingredient and packaging suppliers (permethrin API, excipients, and primary packaging). However, supplier identities are not determinable from the provided information. No source data is supplied that ties specific named companies to “Elimite” manufacture, fill/finish, API supply, or packaging for a specific geography and marketing authorization holder.

As a result, there is no complete, verifiable set of named suppliers to report without introducing unsupported claims.


What Suppliers Are Named for Elimite?

No supplier roster can be produced from the provided prompt. Elimite supplier identification requires at least one of the following evidence types, none of which are included here: a current FDA Orange Book listing with manufacturer details for the specific NDA product; a label-imprint trace (labeler/manufacturer) linked to an accountable site; a country-specific medicines register entry; or a procurement-grade document listing named API/excipient/packaging vendors.


What Can Be Verified About Elimite’s Supply Structure?

Even without named suppliers, the supply structure for a permethrin 5% topical product is consistent:

  • API supply: permethrin (typically manufactured under GMP as an API or purchased in that form)
  • Drug product supply: formulation and fill-finish of permethrin 5% cream (tubed product)
  • Excipients: cream base components (common categories include emulsifiers, solvents, and preservatives)
  • Packaging: laminated tubes and carton packaging with label printing

But this structure does not identify the companies supplying Elimite.


Key Takeaways

  • No named suppliers for Elimite can be provided from the information given.
  • Elimite supply involves API, drug product fill-finish, excipients, and packaging, but company-level identifiers require authoritative listing or label/imprint evidence.

FAQs

1) Is Elimite supplied by a single manufacturer?
Not necessarily. Branded topicals often involve one labeler/manufacturer for finished dosage and separate suppliers for API, excipients, and packaging.

2) Does the supplier change by country?
Yes. Marketing authorization holders and manufacturers can differ by jurisdiction, and distribution can be through different labelers.

3) Can generic “permethrin 5%” suppliers substitute for Elimite suppliers?
They may differ. Generic suppliers are not the same as branded supply-chain counterparts.

4) Where do named suppliers usually appear in official records?
In product listings that identify the marketing authorization holder and the manufacturing site(s), and on the finished product label/imprint.

5) What evidence is needed to list suppliers with high confidence?
Authoritative product-registration or label-imprint evidence tied to the specific Elimite product and marketing authorization.


References (APA)

[1] No sources were provided in the prompt.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.